These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30887254)
1. The exosome secretion inhibitor neticonazole suppresses intestinal dysbacteriosis-induced tumorigenesis of colorectal cancer. Gu L; Xu Y; Xu W; Li M; Su H; Li C; Liu Z Invest New Drugs; 2020 Apr; 38(2):221-228. PubMed ID: 30887254 [TBL] [Abstract][Full Text] [Related]
2. Matrine reduces the secretion of exosomal circSLC7A6 from cancer-associated fibroblast to inhibit tumorigenesis of colorectal cancer by regulating CXCR5. Gu C; Lu H; Qian Z Biochem Biophys Res Commun; 2020 Jun; 527(3):638-645. PubMed ID: 32423804 [TBL] [Abstract][Full Text] [Related]
3. Enhanced therapeutic impact of Shikonin-encapsulated exosomes in the inhibition of colorectal cancer progression. Lu Y; Zhou H; Han C; Gong Y; Li Y; Xia Y; Liang B; Yang H; Wang Z Nanotechnology; 2024 Jul; 35(41):. PubMed ID: 38991510 [TBL] [Abstract][Full Text] [Related]
4. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
5. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer. Li J; Chen Y; Guo X; Zhou L; Jia Z; Peng Z; Tang Y; Liu W; Zhu B; Wang L; Ren C J Cell Mol Med; 2017 May; 21(5):838-847. PubMed ID: 28233416 [TBL] [Abstract][Full Text] [Related]
6. Intestinal dysbacteriosis activates tumor-associated macrophages to promote epithelial-mesenchymal transition of colorectal cancer. Wan G; Xie M; Yu H; Chen H Innate Immun; 2018 Nov; 24(8):480-489. PubMed ID: 30246585 [TBL] [Abstract][Full Text] [Related]
7. Intestinal dysbiosis promotes epithelial-mesenchymal transition by activating tumor-associated macrophages in ovarian cancer. Xu S; Liu Z; Lv M; Chen Y; Liu Y Pathog Dis; 2019 Mar; 77(2):. PubMed ID: 30916767 [TBL] [Abstract][Full Text] [Related]
8. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway. Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765 [TBL] [Abstract][Full Text] [Related]
9. The tumorigenic and therapeutic functions of exosomes in colorectal cancer: Opportunity and challenges. Ahmadi M; Jafari R; Mahmoodi M; Rezaie J Cell Biochem Funct; 2021 Jun; 39(4):468-477. PubMed ID: 33491214 [TBL] [Abstract][Full Text] [Related]
10. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271 [TBL] [Abstract][Full Text] [Related]
11. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer. Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065 [TBL] [Abstract][Full Text] [Related]
12. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells. Huang MB; Gonzalez RR; Lillard J; Bond VC Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321 [TBL] [Abstract][Full Text] [Related]
13. Exosomes: Emerging modulators of signal transduction in colorectal cancer from molecular understanding to clinical application. Bahrami A; Moradi Binabaj M; A Ferns G Biomed Pharmacother; 2021 Sep; 141():111882. PubMed ID: 34218003 [TBL] [Abstract][Full Text] [Related]
14. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721 [TBL] [Abstract][Full Text] [Related]
15. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p. Xu Y; Qiu A; Peng F; Tan X; Wang J; Gong X Neoplasma; 2021 Jan; 68(1):108-118. PubMed ID: 33147048 [TBL] [Abstract][Full Text] [Related]
16. Xiaoyaosan slows cancer progression and ameliorates gut dysbiosis in mice with chronic restraint stress and colorectal cancer xenografts. Zhang Z; Shao S; Zhang Y; Jia R; Hu X; Liu H; Sun M; Zhang B; Li Q; Wang Y Biomed Pharmacother; 2020 Dec; 132():110916. PubMed ID: 33113425 [TBL] [Abstract][Full Text] [Related]
17. The mechanisms underlying the enrichment and action of glypican-1-positive exosomes in colorectal cancer cells. Li J; Chen Y; Yu S; Liao M; Zhou L; Jia Z; Tang Y; Yuan B Transl Oncol; 2023 Jun; 32():101655. PubMed ID: 36963204 [TBL] [Abstract][Full Text] [Related]
18. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice. Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic inhibition of SGK1 suppresses colorectal cancer. Liang X; Lan C; Jiao G; Fu W; Long X; An Y; Wang K; Zhou J; Chen T; Li Y; Xu J; Huang Q; Xu B; Xiao J Exp Mol Med; 2017 Nov; 49(11):e399. PubMed ID: 29170478 [TBL] [Abstract][Full Text] [Related]
20. Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice. Zhu Y; Gu L; Lin X; Zhang J; Tang Y; Zhou X; Lu B; Lin X; Liu C; Prochownik EV; Li Y JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34914638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]